Vericel Corp. (VCEL)
38.34
+0.47
(+1.24%)
USD |
NASDAQ |
Sep 11, 16:00
38.33
-0.01
(-0.03%)
After-Hours: 20:00
Vericel Market Cap : 1.962B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.962B |
| September 10, 2026 | 1.938B |
| September 09, 2026 | 1.995B |
| September 08, 2026 | 2.000B |
| September 04, 2026 | 2.057B |
| September 03, 2026 | 2.071B |
| September 02, 2026 | 2.092B |
| September 01, 2026 | 2.072B |
| August 31, 2026 | 2.042B |
| August 28, 2026 | 2.095B |
| August 27, 2026 | 2.107B |
| August 26, 2026 | 2.172B |
| August 25, 2026 | 2.212B |
| August 24, 2026 | 2.165B |
| August 21, 2026 | 2.184B |
| August 20, 2026 | 2.155B |
| August 19, 2026 | 2.230B |
| August 18, 2026 | 2.265B |
| August 17, 2026 | 2.231B |
| August 14, 2026 | 2.262B |
| August 13, 2026 | 2.279B |
| August 12, 2026 | 2.289B |
| August 11, 2026 | 2.269B |
| August 10, 2026 | 2.249B |
| August 07, 2026 | 2.307B |
| Date | Value |
|---|---|
| August 06, 2026 | 2.290B |
| August 05, 2026 | 2.321B |
| August 04, 2026 | 2.371B |
| August 03, 2026 | 2.356B |
| July 31, 2026 | 2.352B |
| July 30, 2026 | 2.436B |
| July 29, 2026 | 2.386B |
| July 28, 2026 | 2.390B |
| July 27, 2026 | 2.319B |
| July 24, 2026 | 2.298B |
| July 23, 2026 | 2.298B |
| July 22, 2026 | 2.273B |
| July 21, 2026 | 2.354B |
| July 20, 2026 | 2.340B |
| July 17, 2026 | 2.379B |
| July 16, 2026 | 2.439B |
| July 15, 2026 | 2.383B |
| July 14, 2026 | 2.351B |
| July 13, 2026 | 2.422B |
| July 10, 2026 | 2.397B |
| July 09, 2026 | 2.464B |
| July 08, 2026 | 2.398B |
| July 07, 2026 | 2.395B |
| July 06, 2026 | 2.375B |
| July 02, 2026 | 2.396B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 454.35B |
| ADMA Biologics, Inc. | 2.080B |
| Kyntra Bio, Inc. | 32.27M |
| Conexeu Sciences, Inc. | 119.34M |
| ACADIA Pharmaceuticals, Inc. | 4.790B |
Market Cap Related Metrics
| PE Ratio | 82.93 |
| PS Ratio | 6.480 |
| PEG Ratio | 0.306 |
| Price to Book Value | 5.302 |
| Price to Free Cash Flow | 32.19 |
| Price | 38.34 |
| Earnings Yield | 1.21% |
| PEGY Ratio | 0.306 |
| Operating PE Ratio | 108.84 |
| Normalized PE Ratio | 82.95 |